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Condensation: This meta-analysis included ten studies investigating the impact of benign non-1 
endometriotic ovarian cystectomy on ovarian reserve as determined by circulating AMH. The 2 
analysis revealed a marked postoperative reduction of circulating AMH. 3 
 4 
Short title: Impact of ovarian cystectomy on ovarian reserve 5 
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Abstract 1 
Background: Benign non-endometriotic ovarian cysts are very common and often require 2 
surgical excision. However, there has been a growing concern over the possible damaging effect 3 
of this surgery on ovarian reserve. 4 
Objective: The aim of this meta-analysis was to investigate the impact of excision of benign non-5 
endometriotic ovarian cysts on ovarian reserve as determined by serum anti-Müllerian hormone 6 
(AMH) level. 7 
Data Sources: MEDLINE, Scopus, ScienceDirect and Embase were searched electronically. 8 
Study design: All prospective and retrospective cohort studies as well as randomised trials that 9 
analyzed changes of serum AMH concentrations after excision of benign non-endometriotic cysts 10 
were eligible. Twenty-five studies were identified, of which ten were included in this analysis. 11 
Data Extraction: Two reviewers performed the data extraction independently. 12 
Results: Pooled analysis of 367 patients showed a statistically significant decline in serum AMH 13 
concentration after ovarian cystectomy (weighted mean difference (WMD) -1.14 ng/ml; 95%  14 
confidence interval (CI) -1.36 to -0.92; I2=43 %). Subgroup analysis including studies with a three-15 
month follow-up, studies using Gen II AMH assay and studies using IOT AMH assay improved 16 
heterogeneity and still showed significant postoperative decline of circulating AMH (WMD -1.44 17 
[95% CI -1.71 to -1.1; I2= 0%], -0.88 [95% CI -1.71 to -0.04; I2=0%], and -1.56 [95% CI -2.44 to -18 
0.69; I2= 22%] respectively). Sensitivity analysis including studies with low risk of bias and 19 
excluding studies with possible confounding factors still showed a significant decline in circulating 20 
AMH. 21 
Conclusion: Excision of benign non-endometriotic ovarian cyst(s) seems to result in marked 22 
reduction of circulating AMH. It remains to be established whether this reflects a real compromise 23 
to ovarian reserve.  24 
Keywords: anti-Müllerian hormone; benign ovarian cysts; ovarian cystectomy; ovarian reserve  25 
26 
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Introduction: 1 
Benign ovarian cysts are very commonly seen in Gynecological practice with the majority 2 
requiring (excluding functional cysts) surgical excision preferably through the laparoscope. 3 
However, there has been growing evidence suggesting a decline in ovarian reserve as a result of 4 
ovarian cystectomy with possible compromise to fertility potential (1, 2, 3). It remains to be 5 
determined whether this damage to the ovarian reserve is related to the procedure itself or to the 6 
nature, size and laterality of the cyst. 7 
Anti-Müllerian hormone (AMH) is a dimeric glycoprotein, which is a member of the transforming 8 
growth factor family. In the female, it is exclusively secreted by granulosa cells of primary, 9 
preantral and small antral follicles (4-6 mm) (4). It is now well established that circulating AMH 10 
gradually declines with advancing age reflecting the decline in the number of the small antral 11 
follicles, rendering it an ideal marker for the early detection of reduced ovarian reserve. 12 
Furthermore, serum AMH concentration is generally stable with minimal inter- and intra-cycle 13 
fluctuations (5). This makes it an ideal candidate for measuring changes in ovarian reserve 14 
following cyst excision. 15 
To date, several studies have investigated the impact of ovarian cystectomy on ovarian reserve 16 
showing a postoperative decline in circulating AMH (2, 6–19). However, given the relatively small 17 
size of these studies, further evidence is required to allow a firm conclusion. We have previously 18 
conducted a meta-analysis of studies investigating the effect of excision of endometriomas on 19 
ovarian reserve (1).   20 
The aim of this meta-analysis was to investigate the impact of excision of benign non-21 
endometriotic cysts on ovarian reserve as determined by serum AMH levels.   22 
 23 
 24 
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Materials and Methods: 1 
Criteria for study selection  2 
This study was conducted according to the Preferred Reporting Items for Systematic Reviews and 3 
Meta-analyses (PRISMA) guidelines (20). All published cohort studies and randomized trials 4 
(including at least five patients) that investigated the impact of excision of benign non-5 
endometriotic ovarian cysts on ovarian reserve as determined by changes in postoperative serum 6 
AMH concentration were included in this meta-analysis.  7 
Outcome measures 8 
Primary measure: 9 
This included postoperative changes in serum AMH concentration. 10 
Secondary measures: 11 
These included postoperative changes in serum FSH concentration and antral follicle count 12 
(AFC). 13 
Search strategy 14 
An extensive electronic database search was performed using MEDLINE, Scopus, Embase and 15 
ScienceDirect to identify published research articles between January 2000 and January 31, 16 
2016, on the impact of excision of benign ovarian cysts (excluding endometriomas) on ovarian 17 
reserve as determined by serum AMH concentration. No restrictions were placed on language. A 18 
combination of the following search terms was used: laparoscopy, laparotomy, ovarian 19 
cystectomy, excision, anti-Müllerian hormone, benign ovarian cysts, and ovarian reserve. All 20 
searches were carried out by the first author and then independently repeated using the same 21 
criteria by an accredited clinical librarian. All relevant reports were retrieved, and their reference 22 
lists were reviewed manually to identify further studies. A manual search of related articles on 23 
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PubMed was also performed. We also considered published abstracts from conferences. 1 
Data extraction 2 
All the identified papers were evaluated according to a standardized format including study 3 
design, methods, participant characteristics, intervention, and results. Two investigators scored 4 
the studies and collected the information independently. In the case of discrepancies in scoring 5 
between the two investigators, a consensus was reached after discussion or after involvement of 6 
the senior investigator. In five studies the mean±SD was not presented (2, 11, 14, 16, 17). The 7 
authors of these studies were contacted, but only two replied providing the missing data, which 8 
were used in our analysis (11, 14). In another study, which was a conference abstract, the 9 
authors did not describe methods of recruitment (inclusion and exclusion criteria) nor they 10 
specified the type of AMH assay kit (13). This study was included in the initial analysis, but was 11 
excluded from the sensitivity analysis. The authors were contacted to provide the missing 12 
information, but no response was received. 13 
Quality of included studies and risk of bias assessment  14 
The quality and risk of bias of the included studies were assessed using modified Newcastle-15 
Ottawa scale, as previously described (1). The original  Newcastle-Ottawa scale assesses three 16 
main categories including selection, comparability, and outcomes giving a maximum of four, two, 17 
and three stars for each category respectively (21, 22). This scale was modified to suite the 18 
nature of this study giving a maximum of three stars for selection, four for comparability, and two 19 
for outcome criteria. Selection was rated according to recruitment bias, selection of consecutive 20 
patients and power calculation. Comparability was assessed based on studies adjusting their 21 
analysis for four confounders including patients’ age (<40), cyst diameter (>5cm), baseline serum 22 
AMH (≥ 3.1ng/ml) and cyst laterality. Outcome was scored according to completeness of at least 23 
three-month follow-up after surgery. It is generally agreed that a limit of five stars could identify 24 
studies at low risk of bias (23, 24). However, in this study, we have given more weight to 25 
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comparability factors and used the cutoff level of six stars with a minimum of three stars in the 1 
comparability category (1). Table 1 shows the results of quality scores of the studies included in 2 
this analysis. 3 
Data analysis 4 
Pre- and post-operative data including mean ± SD serum concentrations AMH (ng/mL) and FSH 5 
(mIU/mL) and AFC were extracted from the individual studies and pooled using RevMan software 6 
(Review Manager, version 5.1, The Cochrane Collaboration, 2011; The Nordic Cochrane Centre, 7 
Copenhagen, Denmark). The weighted mean difference (WMD) between pre- and post-operative 8 
values was calculated. Statistical heterogeneity was assessed by chi-squared (χ2, or Chi2) test 9 
and I2 statistics. A Chi2 statistic larger than its degree of freedom or an I2 higher than 50% was 10 
indicative of significant heterogeneity between studies. When heterogeneity was significant, a 11 
random-effect model was used for meta-analysis. Fixed effect meta-analysis was used when 12 
there was no significant heterogeneity.  13 
The initial analysis included data from all studies, irrespective of length of follow-up and cyst 14 
characteristics (diameter, laterality and pathological type). In studies with multiple post-operative 15 
measurements at different follow up points, we used the latest AMH level. Further subgroup 16 
analyses of AMH levels were then performed based on the laterality of the excised cysts, AMH 17 
kits used, and duration of follow-up. To examine and account for heterogeneity, a sensitivity 18 
analysis was carried out based on modified Newcastle Ottawa scale for risk of bias as described 19 
above. Studies with the lowest risk of bias were defined as those with a score of ≥6 with at least 20 
three stars on comparability score and using the same surgical approach (laparoscopy). 21 
 22 
Results 23 
A total of 25 articles were identified (Fig. 1). Initially all articles were screened on the basis of the 24 
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title and abstract to exclude studies which were not relevant to our objectives. As a result, ten 1 
articles were viewed in full. 2 
Excluded studies  3 
After the initial screening on the basis of the title and abstract, ten studies did not use AMH to 4 
investigate ovarian reserve after surgery for benign non-endometriotic cyst and were therefore 5 
excluded (25–34). Five further studies were excluded, one due to the small number of patients 6 
(n=3) (19), another study due to extremely low AMH levels (below the sensitivity of AMH assays) 7 
(16) and three studies due to missing the mean±SD of serum AMH concentrations (data were 8 
either presented as median{IQR}) (2, 18) or mean±SE% (17). The authors of the latter three 9 
studies were contacted to provide the AMH data, but no response was received.  10 
Included studies 11 
Details of the included ten studies are shown in table 2. 12 
Study design 13 
The included studies were all cohort studies except one, which was a randomized controlled trial 14 
(RCT) (7). However, both arms of the RCT (laparoscopy and laparotomy) were combined and 15 
included in the initial meta-analysis as a cohort study. One arm (laparoscopy) was then included 16 
in the sensitivity analysis (7). 17 
Participants 18 
Selection criteria were appropriate for all studies. All participants underwent the same type of 19 
surgery (cystectomy) through laparoscopy except one study, where patients were randomly 20 
allocated to either laparoscopy or laparotomy (7). Patients of this RCT were consecutive and were 21 
followed up within their particular group and the results were given separately for each arm of the 22 
RCT. All studies reported inclusion and exclusion criteria that were appropriate except one (13). 23 
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The author of that study was contacted but did not reply. All patients were accounted for in all 1 
studies.  2 
Ovarian cyst diagnosis 3 
Most of the studies reported that the initial diagnosis of the cysts was achieved through 4 
transvaginal ultrasound. The ultrasound scans were performed by Gynecologists with sufficient 5 
experience. Postoperatively, the nature of the cyst was confirmed with histopathological 6 
examination. Six studies reported the mean ± SD cyst diameter (6–9, 12, 15) and six studies 7 
determined the side and laterality of the cysts (6–8, 11, 12,15).  8 
Surgery and length of follow up 9 
All studies included patients undergoing ovarian cystectomy carried out laparoscopically except 10 
one study, which was an RCT comparing laparoscopic versus open cystectomy (7). The length of 11 
follow up was one month in four studies (11, 12, 14, 15), three months in six studies (6, 8, 9, 10, 12 
12, 14), six months in one study (7). 13 
AMH kits 14 
AMH concentration was measured using one of the four available kits. The first one was IOT AMH 15 
/ MIS enzyme immunoassay (EIA) kit (Immunotech, Beckman Coulter, Marseille, France). The 16 
intra- and inter-assay coefficients of variation for the AMH assay were below 12.3% and 14.2%, 17 
respectively, with a detection limit of 0.14 ng/mL (9, 11). Second AMH kit was DSL active 18 
Müllerian- inhibiting substance / AMH ELISA kit (Diagnostic Systems Laboratories, Webster TX). 19 
The intra- and inter-assay coefficients of variation for AMH were 4.6% and 8.0%, respectively, 20 
with a detection limit of 0.017 ng/mL (7, 10, 12, 14). The third kit was the AMH Gen II enzyme 21 
linked immunosorbent assay (ELISA) (Beckman Coulter, Chaska, MN, USA). The intra and enter-22 
assay coefficients of variation for the AMH assay were both below 10%, with a detection limit of 23 
0.08 ng/mL (6, 8). Two studies used this kit including Ergun and co-workers (6) who used the 24 
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modified AMH Gen II kit and Kwon and co-workers who used the original Gen II assay (8). The 1 
fourth kit was the Ultra-Sensitive AMH ELISA Ansh Labs assay (Ansh Labs, UK). The intra and 2 
Inter-assay coefficients of variation for the AMH were 0.02 (2.22/95) and 7.81 (15.62/2), 3 
respectively, with a detection limit of 0.06 ng/ml (15).  4 
Potential source of bias 5 
In all studies, patients were selected in a consecutive fashion (6–15). The selection method was 6 
clearly described making it easy to assess selection bias. 7 
Overall pooled results for all studies 8 
The initial analysis of the ten studies included all 367 patients who underwent cystectomy for 9 
unilateral or bilateral benign non-endometriotic ovarian cysts. The analysis revealed a statistically 10 
significant postoperative fall in serum AMH concentrations (WMD -1.14 ng/ml; 95% confidence 11 
interval (CI) -1.36 to -0.92). Heterogeneity between studies was low (I2 = 43 %) (6–15) (Fig. 2). 12 
Subgroup analysis 13 
Laterality of benign non-endometriotic ovarian cysts 14 
Six studies included 206 patients undergoing unilateral ovarian cystectomy (6–8, 11, 12, 15). 15 
Results showed a statistically significant decline in serum AMH level after surgery (WMD -0.97 16 
ng/ml; 95% CI -1.58 to -0.37; I2= 73%). Bilateral ovarian cystectomy was reported in five studies 17 
including 23 patients (6, 8, 11, 12, 15). Pooled analysis of the data revealed no statistical 18 
significant change in postoperative serum AMH level (WMD -0.80; 95% CI -1.76 to 0.16; I2= 0%).  19 
Studies with different length of follow up  20 
Six studies (n=270) with one-month follow up revealed a statistically significant decline in serum 21 
AMH level (WMD -1.16; 95% CI -1.69 to -0.63; I2= 76%) (7, 9, 11, 12, 14, 15). Similarly, seven 22 
studies (n=253) with a three-month follow up showed a statistically significant fall of serum AMH 23 
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concentration after surgery (WMD -1.44; 95% CI -1.71 to -1.16; I2= 0%) (6, 7, 8, 9, 10, 13, 14).  1 
Studies using different AMH assays 2 
Analysis of four studies (n=197) using DSL AMH kit revealed a statistically significant decline in 3 
postoperative AMH level (WMD -1.18; 95% CI -1.85 to -0.52; I2=81%) (7, 10, 12, 14). Pooled 4 
analysis of two studies (n=56) using Gen II AMH assay showed a statistically significant fall in 5 
postoperative serum AMH level (WMD -0.88; 95% CI -1.71 to -0.04; I2=0%) (6, 8). Two other 6 
studies (n=58) using IOT AMH assay revealed a statistically significant decline in postoperative 7 
AMH level (WMD -1.56; 95% CI -2.44 to -0.69; I2= 22%) (9, 11). Heterogeneity between studies 8 
was low for studies using Gen II and IOT AMH kits. One study used the new Ultrasensitive AMH 9 
ELISA assay an showed significant decline I circulating AMH (15). 10 
Sensitivity analysis 11 
Pooled analysis of eight studies with low risk of bias (as defined above) including 297 patients 12 
showed a statistically significant fall in postoperative serum AMH concentration (WMD -1.05; 95% 13 
CL -1.29 to -0.81; I2= 43%). Heterogeneity between studies was low (6, 7, 8, 9, 11, 12, 14, 15). 14 
Studies with ovarian cyst >5 cm: 15 
Seven studies including 276 patients were identified (6, 7, 8, 9, 12, 14, 15). Pooled analysis 16 
revealed a statistically significant fall in postoperative serum AMH concentration (WMD -1.13; 17 
95% CI -1.56 to -0.70; I2=62%). Heterogeneity between studies was high. 18 
Studies with different histological types  19 
Analysis of six studies including 158 patients with dermoid cysts revealed a statistically significant 20 
fall in serum AMH concentration (WMD -1.27; 95% CI -1.93 to -0.62; I2= 55%) (6, 7, 9, 11, 12, 14). 21 
Similarly, analysis of four studies including 84 patients with cystadenomas showed a statistically 22 
significant decline in serum AMH concentration (WMD -1.59; 95% CI -2.00 to -1.17; I2= 0%) (6, 7, 23 
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11, 14).  1 
Secondary outcomes 2 
Three studies measured changes in serum FSH concentrations (6, 11, 12), but only two (including 3 
95 patients) of them provided full pre- and post-operative data (6, 12). Pooled analysis of these 4 
two studies revealed no significant change in circulating FSH following ovarian cystectomy (WMD 5 
-0.50; 95% CI -1.28 to 0.28; I2= 0%). Authors of the other study (11) reported that FSH levels did 6 
not change after surgery, but failed to present the actual data. 7 
With regards to AFC, although one study included this ovarian reserve marker as an outcome 8 
measure, the authors provided the postoperative AFC data only and failed to present the 9 
preoperative values (7).  10 
Comment 11 
This is the first meta-analysis to investigate the impact of ovarian cystectomy for benign non-12 
endometriotic cysts on ovarian reserve as determined by changes in postoperative serum AMH 13 
concentration. The initial analysis revealed a marked decline of 1.14 ng/ml, which represents 14 
about 38% of the cut-off level of normal AMH (3.1 ng/ml). This decline in AMH seems to be 15 
sustained for up to six months. Further subgroup and sensitivity analysis were performed to 16 
minimise the risk of bias and to take into account all possible confounding factors. Heterogeneity 17 
was lowest between studies using Gen II and IOT AMH kits, studies with three-month follow-up 18 
after surgery and studies including excision of cystadenomas. This further analysis still showed a 19 
statistically significant decline in postoperative serum AMH. 20 
Interestingly, this magnitude of AMH decline is similar to that observed after excision of ovarian 21 
endometriomas as reported in our previous meta-analysis (1). This is surprising as excision of 22 
endometriomas is generally perceived to be more destructive to the ovary than excision of non-23 
endometriotic cysts. This may therefore suggest that the decline in circulating AMH after ovarian 24 
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cystectomy is not related to the nature of the cyst excised. 1 
The mechanism of the observed fall in circulating AMH following ovarian cystectomy remains 2 
largely unknown. Possible explanation could be the concomitant removal of normal ovarian tissue 3 
with significant follicular loss (35). Another possible mechanism is the thermal damage to ovarian 4 
tissue due to excessive use of diathermy for hemostasis (2, 3). 5 
It is interesting to see this marked drop of circulating AMH (about 38%) following unilateral 6 
ovarian cystectomy. It is well established that circulating AMH is generally stable throughout the 7 
reproductive years with minimal inter-cycle variation and with very small and gradual decline with 8 
advancing age until 40. Bentzen and co-workers reported an  AMH level decline of 5.6% per year 9 
(36). We therefore believe that a 38% decline in AMH level after cystectomy represents a 10 
relatively marked drop, which appears to be clinically significant. However, unlike the age related 11 
decline, it is unlikely that the observed post cystectomy AMH fall reflects an equivalent decline in 12 
ovarian reserve and fertility potential. It is well established that circulating AMH corresponds to the 13 
number of small antral follicles, but does not directly correspond to the total follicular pool of the 14 
ovary. It is possible that postoperative fall in AMH reflects loss/damage of small antral follicles, 15 
which are the only source of AMH, but may have no significant impact on the total number of 16 
primordial follicles. In order to investigate this hypothesis, further studies are required to assess 17 
the long term changes in circulating AMH as well as the reproductive performance following 18 
ovarian cystectomy. Until such evidence becomes available, it may be prudent for clinicians to 19 
counsel their patients with regards to the potential damaging effect of cystectomy on ovarian 20 
reserve.  A more conservative approach (if malignancy can be confidently ruled out) could be 21 
considered whenever clinically possible and appropriate such as deferring surgery until 22 
completion of family.  23 
Timing of postoperative serum AMH measurements 24 
The timing of postoperative measurement of circulating AMH varied in the ten studies included in 25 
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this meta-analysis. The majority of studies (Seven studies, n=253) performed the measurement at 1 
three-month follow-up after surgery (6, 7, 8, 9, 10, 13, 14) and one study (7) performed multiple 2 
measurements (n=59). In this study, we used the latest samples, which are likely to reflect the 3 
most sustained change of circulating AMH after surgery. Analysis of studies with repeated AMH 4 
measurements at one and three-month follow-up showed a sustained decline in AMH, indicating 5 
that ovarian reserve does not seem to recover within three months.  6 
Surgery for bilateral ovarian cysts 7 
Although, excision of bilateral ovarian cysts is expected to cause more damage to ovarian 8 
reserve, it was surprising to see that analysis of studies with bilateral cystectomy did not reveal a 9 
significant drop in AMH. However, the numbers included in this analysis was too small (n=23) to 10 
allow any firm conclusion.  11 
Cyst diameter (>5 cm)  12 
The purpose of this analysis was to adjust for the variation in cyst size as a possible confounding 13 
factor. Cyst size did not seem to affect the magnitude of postoperative fall in circulating AMH as 14 
indicated by the WMD, which is similar to that of the overall analysis of all included patients 15 
regardless of the cyst size.  16 
AMH kits 17 
It is well recognized that different AMH kits give different results and have different sensitivities 18 
and inter- and interassay CV. IOT assay (Immunotech, Beckman Coulter, Marseille, France) has 19 
been found to produce AMH concentrations 40% higher compared with DSL  AMH assay (DSL, 20 
Webster, TX, USA), making it difficult to combine/compare results from different studies (37). In 21 
2010 both companies merged under Beckman Coulter and a single new two-step, sandwich-type 22 
enzymatic, microplate assay (the AMH Gen II assay) was introduced. The Gen II assay is 23 
calibrated to the old IOT standards and AMH levels are thus comparable to the IOT assay and 24 
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40% higher than the previous DSL version (38, 39, 40, 41).  1 
Interestingly, studies using AMH Gen II assay showed a significantly smaller postoperative 2 
decline in AMH (WMD -0.88 ng/ml) compared with that observed with IOT kit (WMD -1.56 ng/ml), 3 
and with DSL assay (WMD -1.18 ng/ml). It is difficult to explain this unexpected difference in the 4 
magnitude of AMH decline between Gen II and IOT kits, which have been calibrated to produce 5 
comparable results.   6 
Conclusion 7 
In conclusion, excision of benign non-endometriotic ovarian cyst seems to cause marked decline 8 
(38%) in circulating AMH. Whether this reflects a long term damage to ovarian reserve with 9 
subsequent decline in fertility potential remains to be determined. Given the high heterogeneity 10 
between studies, this meta-analysis should be interpreted with caution. 11 
 12 
 13 
 14 
15 
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Figure legends 1 
Figure 1. PRISMA Flow Chart of the study selection process 2 
 3 
FIG 2. WMD in serum AMH concentrations after excision of benign non-endometriotic 4 
ovarian cysts: pooled results for all ten studies. 5 
 6 
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Table 1 Modified Newcastle Ottawa scale for risk of bias and quality assessment of the included studies 
 
Author Year selection Comparability Outcome Total score 
Chang et al. (10) 2010 * * ** 4 
Iwase et al. (11) 2010 ** *** * 6 
Mohamed et al. (7) 2011 ** **** ** 8 
Kim et al. (13) 2013 * * ** 4 
Chen et al. (15) 2014 ** *** * 6 
Huang et al. (12) 2014 ** **** * 7 
Kwon et al. (8) 2014 ** **** ** 8 
Yoon et al. (9) 2014 ** *** ** 7 
Amooee et al. (14) 2015 ** *** ** 7 
Ergun et al. (6) 2015 * **** ** 7 
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Table 2 Characteristics of the ten studies included in the meta-analysis 
 
Author country Design n Age 
mean±SD Laterality 
Cyst diameter 
mean±sd 
FU 
Months Primary outcome  
Secondary 
Outcome 
Chang et al. 2010 (10) Korea 
Prospective 
cohort 7 33.75±7.20 Not specified Not specified 3 AMH (DSL kit),  – 
Iwase et al. 2011 (11) Japan 
Prospective 
cohort 21 29.40±7.3 
Uni=16 
Bil=5 Not specified 1 AMH (IOT kit),  FSH 
Mohamed et al. 2011 (7) Egypt RCT* 
 
Arm 1=30 
Arm 2=29 
23.00±4.1 All unilateral Arm 1, 5.1±2.2 Arm 2, 5.6±2.0 6 AMH (DSL kit),  AFC 
Kim et al. 2013 (13) 
 
Korea 
Prospective 
cohort 34 Not specified Not specified Not specified 3 AMH (kit not specified) – 
Chen et al. 2014 (15) 
 
China 
Prospective 
cohort 22 29.95 ± 3.92 
Uni=18 
Bil=4 6.35 ± 2.88 1 AMH (Ansh Labs) – 
Huang et al. 2014 (12) Taiwan Retrospective 
case control 71 34.59±10.18 
Uni=67 
Bil=4 7.05±2.37 1 AMH (DSL kit),  FSH 
Kwon et al. 2014 (8) Korea 
Prospective 
cohort 32 30.00±6.23 
Uni=24 
Bil=8 7.28±2.80 3 AMH (original Gen II) – 
Yoon et al. 2014 (9) Korea 
Prospective 
cohort 37 30.30±5.0 Not specified 7.28±2.80 3 AMH (IOT kit) – 
Amooee et al. 2015 (14) Iran 
Prospective 
cohort 60 
25.80 
Average Not specified 
7.6 
Average 3 AMH (DSL kit) – 
Ergun et al. 2015 (6) Turkey 
Prospective 
cohort 24 28.39±6.76 
Uni=22 
Bil=2 5.9±1.98 3 AMH (modified Gen II),  FSH 
 
* RCT Arm 1, laparoscopy; Arm 2, laparotomy 
** SD not available 
Abbreviation: FU, follow up; OV, ovarian volume; Uni, unilateral; Bil, bilateral 
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